Company intelligence / Profile preview

HITLAB

New York, New York, United Stateshitlab.org ↗

Ownership: Private
Development stage: Other

Overview

HITLAB specializes in designing and running rapid scientific studies to validate new healthcare technologies. It has supported early detection of cognitive diseases through clinical studies and developed analytics tools for oncology care pathways. Its accelerator programs help startups move from concept to market by providing real-world testing with clinical partners.

Therapeutic areas: OtherOncologyNeurologyWomen's Health
Modalities: DeviceDigital health technologyNon-pharmacological therapy
Industry: Contract Research Organization

Partnerships

Merck Global Health Innovation FundJohnson & JohnsonMedidataNew York City Economic Development CorporationNorthwell HealthAtlas VentureStartUp Health

Beyond the preview

Go deeper on HITLAB.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on HITLAB.

Explore the full profile